You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Technical issues, regulatory hurdles, societal stagnancy. All three of these pose a threat to the advancement of personalized medicine. But perhaps the greatest issue, according to Xconomy's Luke Timmerman, is a lack of sufficient samples.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?Login Now.
Don't have a GenomeWeb or 360Dx account?Register for Free.
Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.
A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.
In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.
According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.